XML 40 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Note 8 - Preferred Stock and Common Stock Warrants
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note
8
– Preferred Stock and
 
Common Stock Warrants
 
Preferred Stock
 
In
August 2018,
we sold an aggregate of
50,000
shares of Series A Convertible Preferred Stock, par value
$0.0001
per share (the “Series A Preferred Stock), at
$1,000
per share for an aggregate purchase price of
$50
million and we issued an additional
1,000
shares of Series A Preferred Stock in aggregate as origination fees to the purchasers of the Series A Preferred Stock.  In
September 2018
and
May 2019,
we sold an aggregate of
29,055
shares and
20,945
shares, respectively, of Series B Convertible Preferred Stock, par value
$0.0001
per share (the “Series B Preferred Stock” and, together with the Series A Preferred Stock, the “Convertible Preferred Stock”), at
$1,000
per share for a combined purchase price of
$50
million and we issued an additional
999
shares of Series B Preferred Stock in aggregate as origination fees to the purchasers of the Series B Preferred Stock. Warrants were issued together with the shares of Convertible Preferred Stock (the “Common Stock Warrants”).
 
The shares of Convertible Preferred Stock bear dividends at a rate of
12%
per annum, which are cumulative and accrue daily from the date of issuance on the
$1,000
stated value.  Such dividends are payable quarterly and
may
be paid in cash or in-kind.  During the
nine
months ended
September 30, 2019
, the Company paid-in-kind
$4.8
million and
$3.0
million of dividends to the holders of the Series A Preferred Stock and the Series B Preferred Stock, respectively.  On
October 15, 2019,
the Company paid-in-kind
$1.7
million and
$1.6
million of dividends to the holders of the Series A Preferred Stock and the Series B Preferred Stock, respectively, as of the close of business on
September 15, 2019.
 
Common Stock Warrants
 
 
Pursuant to ASC
815
-
40,
Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock
, the fair value of the Common Stock Warrants was recorded as a non-current liability on our Consolidated Balance Sheet on the issuance dates.  The Company revalues the Common Stock Warrants at each balance sheet date and recognized a gain of
$0.9
million and a loss of  approximately
$1.0
million during each of the
three
and
nine
months ended
September 30, 2019
, respectively. The Common Stock Warrants are included in Level
3
of the fair value hierarchy.
 
The Common Stock Warrants have a fixed
three
-year term commencing on the closings of each issuance of the associated Convertible Preferred Stock.  The Common Stock Warrants
may
only be exercised by the holders thereof at the expiration of such
three
-year term; however, the Company can force exercise of the Common Stock Warrants prior to expiration of such term if the volume weighted average trading price of shares of Company common stock for each trading day during any
60
of the prior
90
trading days is equal to or greater than
175%
of the Conversion Price (as defined in the certificate of designations of the applicable Convertible Preferred Stock) and, in the case of the warrants issued together with the Series B Preferred Stock (the “Series B Warrants”), also if the Company simultaneously elects to force a mandatory exercise of all other warrants then outstanding and unexercised and held by any holder of parity stock. 
 
The Company used a Monte Carlo simulation model to estimate the fair value of the Common Stock Warrants using the following assumptions:
 
   
September 30,
   
December 31,
 
   
2019
   
2018
 
Stock price
  $
5.76
    $
5.40
 
Exercise price
  $
0.01
    $
0.01
 
Risk-free rate
   
1.6
%    
2.5
%
Volatility
   
27.0
%    
33.1
%
Term (years)
   
2.1
     
2.7
 
 
Beneficial Conversion Feature
 
 
ASC
470
-
20
-
20
Debt – Debt with conversion and Other Options
(“ASC
470
-
20”
) defines a beneficial conversion feature (“BCF”) as a nondetachable conversion feature that is in the money at the issuance date.  The Company was required by ASC
470
-
20
to allocate a portion of the proceeds from the Series A Preferred Stock equal to the intrinsic value of the BCF to additional paid-in capital. We are recording the accretion of the
$2.5
million Series A Preferred Stock discount attributable to the BCF as a deemed dividend using the effective yield method over the period prior to the expected conversion date. Deemed dividends on the Series A Preferred Stock was
$0.3
million for each of the
three
months ended
September 30, 2019
and
2018
, and
$1.3
million and
$0.3
million for each of the
nine
months ended
September 30, 2019
and
2018
, respectively.
 
Initial Fair Value Allocation
 
 
Net cash proceeds from the sale of the Series B Preferred Stock in
May
2019
were allocated on a fair value basis to the Series B Warrants and on a relative fair value basis to the Series B Preferred Stock.
 
The allocation of the net cash proceeds is as follows (in thousands):
 
     
 
 
 
Allocation of Proceeds
 
     
 
 
   
 
 
 
Series B
 
     
 
 
 
Series B
   
Preferred
 
     
 
 
 
Warrants
   
Stock
 
Gross proceeds
  $
20,945
     
 
     
 
 
Equity issuance costs
   
     
 
     
 
 
Net proceeds - Initial Fair Value Allocation
  $
20,945
    $
1,936
    $
19,009
 
Per balance sheet upon issuance
   
 
    $
1,936
    $
19,009